Search results
Showing 1111 to 1125 of 1422 results for social care
Rovalpituzumab tesirine for treating small-cell lung cancer after 2 therapies [ID1288]
Discontinued [GID-TA10212]
Durvalumab for untreated unresectable hepatocellular carcinoma [ID4068]
Discontinued [GID-TA11041]
In development [GID-TA10841] Expected publication date: TBC
In development [GID-TA10696] Expected publication date: TBC
Atezolizumab with paclitaxel for untreated advanced triple-negative breast cancer [ID2705]
Discontinued [GID-TA10570]
Nivolumab for small-cell lung cancer after platinum-based chemotherapy [ID1126]
Discontinued [GID-TA10158]
Atezolizumab for untreated advanced renal cell carcinoma [ID1365]
Discontinued [GID-TA10338]
Cabozantinib for previously treated advanced renal cell carcinoma (TA463)
Evidence-based recommendations on cabozantinib (Cabometyx) for previously treated advance renal cell carcinoma in adults.
Pembrolizumab with chemotherapy for untreated metastatic urothelial cancer ID1545
Discontinued [GID-TA10418]
Discontinued [GID-TA10196]
Ixazomib with lenalidomide and dexamethasone for untreated multiple myeloma [ID1170]
Discontinued [GID-TA10254]
Evidence-based recommendations on pemetrexed (Alimta) for locally advanced or metastatic non-squamous non-small-cell lung cancer in adults who have had pemetrexed and cisplatin.